InsiderClue
Stocks · Industrials · Services-Testing Laboratories

20/20 Biolabs, Inc.

AIDX Clue Score47
United States Fiscal year ends December CIK 0001139685
$0.38 -1.06% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.38 −79.62% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 19 Feb 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue1.8Operating income−5.7Net income−5.6EPS, diluted−1.16Fiscal year 2025Revenue2.0 +16.7%Operating income−3.3Net income−3.7EPS, diluted−0.76
FY2024FY2025
Revenue 1.8 2.0
Growth +16.7%
Operating income −5.7 −3.3
Net income −5.6 −3.7
Growth
EPS, diluted −1.16 −0.76
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin20.6%Operating margin−324.0%Net margin−316.8%Fiscal year 2025Gross margin29.6%Operating margin−162.9%Net margin−182.8%
FY2024FY2025
Gross margin 20.6% 29.6%
Operating margin −324.0% −162.9%
Net margin −316.8% −182.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2024Operating cash flow−2.6Fiscal year 2025Operating cash flow−1.9
FY2024FY2025
Operating cash flow −2.6 −1.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash1.8Shareholders’ equity1.5Fiscal year 2025Cash1.0Shareholders’ equity−0.0
FY2024FY2025
Cash 1.8 1.0
Shareholders’ equity 1.5 −0.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−2.6 −1.9
Growth
0.1 0.1
Financing
0.3 1.2

Capital expenditure, dividends and buybacks are shown as money out, so negative.